BackEloxx Pharmaceuticals Overview

Eloxx Pharmaceuticals Other Current Liabilities

Track Eloxx Pharmaceuticals's other current liabilities ($13M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$13.06M

Peer average / median

Loading

Eloxx Pharmaceuticals Other Current Liabilities History

Loading

Eloxx Pharmaceuticals vs. peers: Other Current Liabilities Comparison

Loading

Eloxx Pharmaceuticals Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Eloxx Pharmaceuticals (ELOX) FAQ

The latest other current liabilities for ELOX is $13M as of March 2026. Investors often review this figure alongside Eloxx Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

A other current liabilities figure of $13M for ELOX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ELOX's other current liabilities ($13M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Eloxx Pharmaceuticals's other current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.